Discover how Sandoz is transforming healthcare with high-quality, affordable medicines and biosimilars for people around the world. Sandoz The Sandoz brand exists today as a subsidiary of Novartis. Sandoz is the generic drugs division of Novartis. The Sandoz brand is a seal of quality, and healthcare professionals around the world trust it as a symbol of high-quality, affordable medications. Sandoz Inc. manufactures, markets and/or distributes more than 174 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. [4] Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Its leading portfolio of approximately 1,300 products addresses diseases from the common cold to cancer. Headquartered in Basel, Switzerland, Sandoz traces its heritage back to 1886. At Sandoz, we discover new ways to improve and extend people’s lives and pioneer novel approaches to help people around the world access high-quality medicine. Sandoz completed its long-heralded separation from Novartis on schedule this morning, with its shares trading at CHF 24 on the SIX Swiss Exchange. Sandoz Today Sandoz is a standalone company having broken away from Novartis in 2023. It is a big pharmaceutical firm in Switzerland. Today, Sandoz produces many drugs whose patents have run out (so called generic drugs). The original company, which was founded in 1886, is known for several things: It invented saccharin in 1899.